Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

SBIR grant awarded to Vion to advance preclinical development of TAPET vectors

Jan. 20, 2000

Gliatech and Abgenix enter XenoMouse technology collaboration

Jan. 20, 2000

Oxford BioMedica's LentiVector has potential application in cancer

Jan. 20, 2000

Phoenix and CuraGen enter transgenic research agreement

Jan. 20, 2000

AxyS announces combinatorial chemistry agreement with Searle

Jan. 19, 2000

Tripos and Parke-Davis to jointly develop high-throughput screening methods

Jan. 19, 2000

Xechem awarded SBIR grant for marine extremophile research

Jan. 19, 2000

Patent coverage granted for Cell Genesys's third-generation lentiviral vectors

Jan. 18, 2000

Protein Design Labs and Celltech Chiroscience enter antibody patent agreement

Jan. 18, 2000

Pharmacopeia achieves milestone in Schering collaboration

Jan. 18, 2000

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...